Clik here to view.
Cryptos Unite! Lock down those iPad patient data leaks!
You know all those shiny iPads in the hands of doctors? The ones that are used during office visits, replacing the old paper charts? Now that doctors are embracing Electronic Health Records and working...
View ArticleClik here to view.
When the right platform presents itself, jump on and go!
The PC and then the Internet technology revolutions disrupted nearly every industry. Sectors like travel, bookstores, and even mapmaking were turned on their heads. But one industry has been impervious...
View ArticleClik here to view.
Stepping into Your Customers’ Shoes
Physicians are justifiably skeptical when a drug rep walks in the door. The relationship is purely transactional. The rep wants the doc to commit to writing more of whatever the rep is selling. The...
View ArticleClik here to view.
The Future of Pharma: Revolution? Really…?
Revolution often begins quietly, at the edges. By the time the mainstream recognizes what is happening, the change is virtually unstoppable. Only in hindsight can one glimpse the seeds of change taking...
View ArticleClik here to view.
Deeper Relationships in Pharma: The “Give To Get” Side of Marketing, Part II
Recently I wrote about the idea of “Give To Get” marketing, the premise that you need to give value to your prospective customers before you ask them for their business. To further reinforce this...
View ArticleClik here to view.
Three Key Strategies to Drive Better Patient Care
When it comes to health technology and new mobile apps, we often jump right into a discussion about cool features and social media. But the real question should be impact. What positive impact are we...
View ArticleClik here to view.
The Rise of Multi-Channel Healthcare Delivery
Last week at Health 2.0, the XPRIZE Foundation announced the winners of the Nokia Sensing Challenge, a $2.25 million global competition to accelerate the development of sensors and sensing technology...
View ArticleClik here to view.
Good patient data is not always meaningful patient data
I’ve been thinking recently about some of the newer sources of health data, namely patient-generated data. My working headline is something like “Good patient data is not always meaningful patient...
View ArticleClik here to view.
What will make Patient Data Meaningful to Patients and Physicians?
In my last blog posting I noted that the thousands of health apps available today are beginning to generate good, accurate patient data. But just because the data is accurate doesn’t mean it’s...
View ArticleClik here to view.
The Touch of an Imerman Angel.
The phone rings. It’s your doctor with the biopsy results and the news isn’t good. Cancer. Just the word itself takes your breath away. You feel dizzy. Amidst swirling emotions of fear and uncertainty,...
View ArticleClik here to view.
Creating Pharma(x)
Mention change in the pharma industry today and you’ll get raised eyebrows along with a sarcastic alliterative remark suggesting you must be Sherlock Holmes… No, the question is not whether change is...
View ArticleClik here to view.
FDA Loosens Regulatory Reins on Digital Devices
Over the past year there have been a series of draft letters from the FDA on the approval process for medical devices, particularly in the arena of digital health. After several years of being a...
View ArticleClik here to view.
Pharma and its Innovator’s Dilemma
A recent conversation with a friend in the pharma industry validated my thoughts and concerns about the systemic challenges that pharma is facing. The pivotal insight came from my friend’s comment that...
View ArticleClik here to view.
The Land of Oz
Dr. Oz and celebrity doctors like him have stirred up the medical community. Regardless of what you think about the accuracy of Dr. Oz’s claims and advice, he has created a huge audience of four...
View ArticleClik here to view.
Pharma Moves Into Digital Health
The announcement that Novartis and Qualcomm Ventures have formed a joint venture to invest $100 million in digital health is significant and suggests that big pharma is transitioning from talk to...
View Article